Utility of IL-6 in the diagnosis, treatment and prognosis of COVID-19 patients: A longitudinal study

Vikram Jain, Pratap Kumar, Prasan Kumar Panda, Karan Kaushal, Anissa A Mirza, S Vivekandan
doi: https://doi.org/10.1101/2022.08.07.22278524

Article Information

doi 
https://doi.org/10.1101/2022.08.07.22278524
History 
  • August 9, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Vikram Jain1,
  2. Pratap Kumar1,
  3. Prasan Kumar Panda1,*,
  4. Karan Kaushal2,
  5. Anissa A Mirza2 and
  6. S Vivekandan2
  1. 1Department of Internal Medicine (ID Division)
  2. 2Department of Biochemistry, AIIMS Rishikesh
  1. ↵*Corresponding author
    Prasan Kumar Panda, Asso. Professor, Dept. of Medicine, Sixth Floor, College Block, All India Institute of Medical Sciences (AIIMS), Rishikesh, India, 249203, Mob: +91-9868999488, motherprasanna{at}rediffmail.com
Back to top
Posted August 09, 2022.
Download PDF
Data/Code
Email
Utility of IL-6 in the diagnosis, treatment and prognosis of COVID-19 patients: A longitudinal study
Vikram Jain, Pratap Kumar, Prasan Kumar Panda, Karan Kaushal, Anissa A Mirza, S Vivekandan
medRxiv 2022.08.07.22278524; doi: https://doi.org/10.1101/2022.08.07.22278524
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area